Bayesian Capital Management, LP Moderna, Inc. Transaction History

Bayesian Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $5.14 Million - $6.97 Million	-43,400 Reduced 94.45%	2,548 $309,000
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $4.79 Million - $6.95 Million	35,300 Added 331.52%	45,948 $7.06 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $1.86 Million - $3.31 Million	-15,752 Reduced 59.67%	10,648 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $3.12 Million - $5.13 Million	26,400 New	26,400 $3.12 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $7.29 Million - $13.2 Million	-56,100 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $6.12 Million - $10.4 Million	56,100 New	56,100 $7.35 Million
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $3.84 Million - $9.92 Million	-58,406 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $3.17 Million - $5.54 Million	58,406 New	58,406 $4.13 Million
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $456,324 - $1.23 Million	-15,380 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $273,456 - $485,700	15,380 New	15,380 $461,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.